Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)


Open article in different language:  DE  |  FR  |  IT
Art. 39 Granting the licence

1 The li­cence is gran­ted if:

a.
the ap­plic­a­tion is com­plete;
b.
the ap­plic­ant ful­fils all rel­ev­ant con­di­tions at all fa­cil­it­ies for the activ­it­ies ap­plied for.

2 Swiss­med­ic shall sus­pend the sub­stant­ive as­sess­ment of the ap­plic­a­tion if crim­in­al pro­ceed­ings are pending against a Re­spons­ible Per­son in ac­cord­ance with Art­icles 5, 6, 17, 18, 23 or 26, as a res­ult of which Swiss­med­ic con­cludes that the con­di­tions for ad­equate tech­nic­al su­per­vi­sion are no longer ful­filled.

3 If a Re­spons­ible Per­son is un­der in­vest­ig­a­tion for in­fringing the TPA or the Nar­cot­ics Act of 3 Oc­to­ber 195111 in crim­in­al pro­ceed­ings, Swiss­med­ic may sus­pend the cor­res­pond­ing li­cence.

4 It may de­mand a stand­ard private ex­tract from the VOSTRA in­form­a­tion sys­tem of the Re­gister of Crim­in­al Re­cords or an ex­tract from a for­eign crim­in­al re­cords re­gister.12

5 The ap­plic­ant is gran­ted a single li­cence for all activ­it­ies in the ap­plic­a­tion in ac­cord­ance with the TPA and this Or­din­ance.

11 SR 812.121

12 Amended by An­nex 10 No II 24 of the Crim­in­al Re­cords Re­gister Or­din­ance of 19 Oct. 2022, in force since 23 Jan. 2023 (AS 2022 698).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden